WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Why Is Regentis Biomaterials Stock Rising On Wednesday? - Regentis Biomaterials (AMEX:RGNT)

Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement and accelerating European commercialization for GelrinC.

Raccontata dabenzinga.commorningstar.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
benzinga.comStai leggendo5 g fa

Why Is Regentis Biomaterials Stock Rising On Wednesday? - Regentis Biomaterials (AMEX:RGNT)

Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement and accelerating European commercialization for GelrinC.

originale
morningstar.com5 g fa

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

HERZLIYA, IL / ACCESS Newswire / June 17, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today…

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 17 giugno 2026·benzinga.com

    Why Is Regentis Biomaterials Stock Rising On Wednesday? - Regentis Biomaterials (AMEX:RGNT)

    Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement and accelerating European commercialization for GelrinC.

  2. giovedì 18 giugno 2026·morningstar.com

    Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

    HERZLIYA, IL / ACCESS Newswire / June 17, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on…